Serum level of high sensitive C-reactive protein and IL − 6 markers in patients with treatment-resistant schizophrenia in Ethiopia: a comparative study

Challa, Feyissa, Seifu, Daniel, Sileshi, Meron, Getahun, Tigist, Geto, Zeleke, Kassa, Desta, Alemayehu, Melkam, Mesfin, Miraf, Fekadu, Abebaw and Woldeamanuel, Yimtubezinash (2021) Serum level of high sensitive C-reactive protein and IL − 6 markers in patients with treatment-resistant schizophrenia in Ethiopia: a comparative study. BMC Psychiatry, 21 (1). a428 1-8. ISSN 1471-244X

[img] PDF - Published Version
Available under License Creative Commons Attribution.

Download (629kB)

Abstract

Background
Accumulating evidence indicates that schizophrenia is accompanied by significant activation of the immune system; however, there is limited data from low and middle-income countries (LMIC). Inflammatory markers may be more relevant in LMIC settings where infectious conditions are more prevalent and may thus play some role in the causation and maintenance of schizophrenia. The aim of this study was to assess the level of inflammatory markers high sensitive C-reactive protein (hsCRP) and interleukin-6 (IL-6) in patients with schizophrenia.

Materials and methods
The study population consisted of a total of 132 study participants; 82 participants with schizophrenia and 50 controls. hsCRP and IL-6 were measured using Cobas Integra 400 Plus and Cobas e 411 analysers respectively.

Results
The levels of hsCRP and IL-6 were significantly increased among participants with schizophrenia compared to controls: hsCRP mean value 2.87 ± 5.6 vs 0.67 ± 0.6 mg/L; IL-6 mean value 6.63 ± 5.6 vs 3.37 ± 4.0 pg/ml. Controlling for potential confounders (age, sex and body mass index), having a diagnosis of schizophrenia remained significantly associated with increased hsCRP and IL-6.

Conclusion
The results confirm that inflammatory processes may have a role in the pathophysiology of schizophrenia regardless of setting. Despite failure of some interventions with anti-inflammatory properties, interventions to reduce inflammation are still worth pursuing.

Item Type: Article
Keywords: Ethiopia, High sensitive C - reactive protein (hsCRP), Inflammatory markers, Interleukin-6 (IL-6), Schizophrenia, Biomarkers, C-Reactive Protein, Ethiopia, Humans, Inflammation, Interleukin-6, Schizophrenia
Schools and Departments: Brighton and Sussex Medical School > Global Health and Infection
SWORD Depositor: Mx Elements Account
Depositing User: Mx Elements Account
Date Deposited: 17 Jan 2022 16:06
Last Modified: 17 Jan 2022 16:15
URI: http://sro.sussex.ac.uk/id/eprint/103885

View download statistics for this item

📧 Request an update